The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139

被引:35
作者
Asaduzzaman, M
Ryan, ET
John, M
Hang, L
Khan, AI
Faruque, ASG
Taylor, RK
Calderwood, SB
Qadri, F [1 ]
机构
[1] ICDDR B, Lab Sci Div, Dhaka 1212, Bangladesh
[2] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA USA
[3] Dartmouth Coll Sch Med, Dept Microbiol & Immunol, Hanover, NH USA
关键词
D O I
10.1128/IAI.72.8.4448-4454.2004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Diarrhea caused by Vibrio cholerae is known to give long-lasting protection against subsequent life-threatening illness. The serum vibriocidal antibody response has been well studied and has been shown to correlate with protection. However, this systemic antibody response may be a surrogate marker for mucosal immune responses to key colonization factors of this organism, such as the toxin-coregulated pilus (TCP) and other factors. Information regarding immune responses to TCP, particularly mucosal immune responses, is lacking, particularly for patients infected with the El Tor biotype of V. cholerae O1 or V cholerae O139 since highly purified TcpA from these strains has not been available previously for use in immune assays. We studied the immune responses to El Tor TcpA in cholera patients in Bangladesh. Patients had substantial and significant increases in TepA-specific antibody-secreting cells in the circulation on day 7 after the onset of illness, as well as similar mucosal responses as determined by an alternate technique, the assay for antibody in lymphocyte supernatant. Significant increases in antibodies to TcpA were also seen in sera and feces of patients on days 7 and 21 after the onset of infection. Overall, 93% of the patients showed a TcpA-specific response in at least one of the specimens compared with the results obtained on day 2 and with healthy controls. These results demonstrate that TcpA is immunogenic following natural V. cholerae infection and suggest that immune responses to this antigen should be evaluated for potential protection against subsequent life-threatening illness.
引用
收藏
页码:4448 / 4454
页数:7
相关论文
共 30 条
[1]   Detection of antibodies to toxin-coregulated pili in sera from cholera patients [J].
Attridge, SR ;
Wallerström, G ;
Qadri, F ;
Svennerholm, AM .
INFECTION AND IMMUNITY, 2004, 72 (03) :1824-1827
[2]   RESPONSE OF MAN TO INFECTION WITH VIBRIO-CHOLERAE .1. CLINICAL, SEROLOGIC, AND BACTERIOLOGIC RESPONSES TO A KNOWN INOCULUM [J].
CASH, RA ;
MUSIC, SI ;
LIBONATI, JP ;
SNYDER, MJ ;
WENZEL, RP ;
HORNICK, RB .
JOURNAL OF INFECTIOUS DISEASES, 1974, 129 (01) :45-52
[3]   RESPONSE OF MAN TO INFECTION WITH VIBRIO-CHOLERAE .2. PROTECTION FROM ILLNESS AFFORDED BY PREVIOUS DISEASE AND VACCINE [J].
CASH, RA ;
MUSIC, SI ;
LIBONATI, JP ;
CRAIG, JP ;
PIERCE, NF ;
HORNICK, RB .
JOURNAL OF INFECTIOUS DISEASES, 1974, 130 (04) :325-333
[4]   Development of a novel in vitro assay (ALS assay) for evaluation of vaccine-induced antibody secretion from circulating mucosal lymphocytes [J].
Chang, HS ;
Sack, DA .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2001, 8 (03) :482-488
[5]   Type IV pilin structure and assembly:: X-ray and EM analyses of Vibrio cholerae toxin-coregulated pilus and Pseudomonas aeruginosa PAK pilin [J].
Craig, L ;
Taylor, RK ;
Pique, ME ;
Adair, BD ;
Arvai, AS ;
Singh, M ;
Lloyd, SJ ;
Shin, DS ;
Getzoff, ED ;
Yeager, M ;
Forest, KT ;
Tainer, JA .
MOLECULAR CELL, 2003, 11 (05) :1139-1150
[6]   A NOVEL 2 COLOR ELISPOT ASSAY .1. SIMULTANEOUS DETECTION OF DISTINCT TYPES OF ANTIBODY-SECRETING CELLS [J].
CZERKINSKY, C ;
MOLDOVEANU, Z ;
MESTECKY, J ;
NILSSON, LA ;
OUCHTERLONY, O .
JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 115 (01) :31-37
[7]   THE ACCESSORY COLONIZATION FACTOR AND TOXIN-COREGULATED PILUS GENE CLUSTERS ARE PHYSICALLY LINKED ON THE VIBRIO-CHOLERAE-0395 CHROMOSOME [J].
EVERISS, KD ;
HUGHES, KJ ;
PETERSON, KM .
DNA SEQUENCE, 1994, 5 (01) :51-55
[8]   SEROEPIDEMIOLOGICAL STUDIES OF EL-TOR CHOLERA IN BANGLADESH - ASSOCIATION OF SERUM ANTIBODY-LEVELS WITH PROTECTION [J].
GLASS, RI ;
SVENNERHOLM, AM ;
KHAN, MR ;
HUDA, S ;
HUQ, MI ;
HOLMGREN, J .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (02) :236-242
[9]   IMMUNOGENICITY OF VIBRIO-CHOLERAE O1 TOXIN-COREGULATED PILI IN EXPERIMENTAL AND CLINICAL CHOLERA [J].
HALL, RH ;
LOSONSKY, G ;
SILVEIRA, APD ;
TAYLOR, RK ;
MEKALANOS, JJ ;
WITHAM, ND ;
LEVINE, MM .
INFECTION AND IMMUNITY, 1991, 59 (07) :2508-2512
[10]   Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio cholerae [J].
Hang, L ;
John, M ;
Asaduzzaman, M ;
Bridges, EA ;
Vanderspurt, C ;
Kirn, TJ ;
Taylor, RK ;
Hillman, JD ;
Progulske-Fox, A ;
Handfield, M ;
Ryan, ET ;
Calderwood, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (14) :8508-8513